Moreover, a study using CCl4-induced liver damage showed that NEU3 inhibition reduced macrophage infiltration, pro-inflammatory cytokines and suppressed fibrosis markers [70], implicating it in the transition from steatosis to nonalcoholic steatohepatitis (NASH). This evidence concerns the gene NEU3 and metabolic dysfunction-associated steatohepatitis.